NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Evestra, Inc.

Evestra, Inc.

Private
Schertz, TexasHealthcare & Life Scienceshttps://evestra.com/

Last Round

Grant

Sep 6, 2022

Total Funding Raised

$23M

Company Overview

Evestra, Inc. is a biopharmaceutical company that develops innovative products in women's healthcare and oncology using steroid medicinal chemistry and vaginal drug delivery technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

women's healthvaginal drug deliverylong-acting contraceptivesoncology therapeuticsmedicinal chemistrycurrent good manufacturing practicecGMPcontract manufacturingactive pharmaceutical ingredientAPIdrug developmentfemtechCDMOanalytical testingbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evestra, Inc. Comparables

Compare Evestra, Inc. with similar companies based on industry and business-model similarity.

Evestra, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VaRi Bioscience GmbH
81%
AnelleO
78%
Daré Bioscience Inc
76%

Evestra, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 6, 2022
GrantMar 30, 2022
GrantNov 1, 2020
StrategicJul 22, 2019
GrantJan 24, 2017
Seed
May 12, 2008

Key People

Founding team and executive leadership

Zeev Shaked

President and CEO

Executive Team

Evestra, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2022

    $960K grant received from the United States Department of Defense.

  • Nov 1, 2020

    $16M grant received from the Gates Foundation.

Evestra, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evestra, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evestra, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSchertz, Texas
Employee Range17
Year Founded2008
Last FundingSep 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.